Activity value 71pakistan Buyer,Last transaction date:
2026-01-20
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for cinarazi pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 1 transactions, with a transaction quantity of 3360 and a transaction weight of 0.
YearTransactionsQuantityWeight
20254134400
2026133600
Bill of lading data
<
1/15
>
Trade date
2026/01/20
B/L No.
——
Suppliers
shandong new time pharmaceuticals co.ltd.
Buyers
cinarazi pharma
Product description
TS1 TEGAFUR GIMERACIL AND OTERACIL POTASSIUM CAPSULE 20MG/CAPSULE QTY = 5040 CAPSULES. BRAND/ORIGIN: SHANDONG NEW ERA PHARMACEUTICAL CO LTD / CHINA
Expand
Trade date
2024/06/20
B/L No.
——
Suppliers
shandong new time pharmaceuticals co.ltd.
Buyers
cinarazi pharma
cinarazi pharma is pakistan Buyer,
and primarily engages in the import and export business of products such as gimeracil,oteracil potassium,capsule.
According to the 52wmb.com global trade database, as of 2026-01-20, the company has completed 18 international trades,
with its main trading regions covering china,costa rica etc.
The core products include HS30049099 etc,
often transported via karachi air frieght unit icg,port kpaf etc,
and its main trading partners are shandong new time pharmaceuticals co.ltd.,shandong new time pharma co.ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on cinarazi pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.